| 注册
首页|期刊导航|中国防痨杂志|中和汤辅助治疗气血两虚证脓肿型淋巴结结核的随机对照研究短期疗效观察

中和汤辅助治疗气血两虚证脓肿型淋巴结结核的随机对照研究短期疗效观察

赵丽萍 梁博文 曹艳华 李波 罗敬月 王桂荣 黄麦玲 宗星煜 曹玉清 姜慧 蔡秋杰 马艳 穆婷婷 刘晓明 刘斌

中国防痨杂志2026,Vol.48Issue(7):1044-1050,7.
中国防痨杂志2026,Vol.48Issue(7):1044-1050,7.DOI:10.19982/j.issn.1000-6621.20250480

中和汤辅助治疗气血两虚证脓肿型淋巴结结核的随机对照研究短期疗效观察

Adjuvant therapy with Zhonghe Decoction for abscess lymph node tuberculosis with Qi and blood deficiency syndrome:a randomized controlled trial on short-term efficacy

赵丽萍 1梁博文 1曹艳华 1李波 1罗敬月 1王桂荣 2黄麦玲 3宗星煜 4曹玉清 4姜慧 5蔡秋杰 4马艳 4穆婷婷 4刘晓明 5刘斌5

作者信息

  • 1. 首都医科大学附属北京胸科医院中医科,北京 101149
  • 2. 首都医科大学附属北京胸科医院检验科,北京 101149
  • 3. 首都医科大学附属北京胸科医院结核科,北京 101149
  • 4. 中国中医科学院中医临床基础医学基础所疫病防治研究室,北京 100700
  • 5. 首都医科大学附属北京胸科医院科技处,北京 101149
  • 折叠

摘要

Abstract

Objective:To evaluate the short-term efficacy of Zhonghe Decoction as an adjuvant therapy for abscess lymph node tuberculosis with Qi and blood deficiency syndrome.Methods:A prospective randomized controlled design was adopted.A total of 80 patients with non-drug-resistant cervical abscess lymph node tuberculosis(Qi and blood deficiency syndrome)admitted to Beijing Chest Hospital,Capital Medical University from January 2022 to December 2024 were enrolled and randomly divided into an observation group and a control group,with 40 cases in each group.After 7 dropouts,36 cases were finally included in the observation group and 37 cases in the control group.Both groups received the H-R-Z-E(Isoniazid,Rifampicin,Pyrazinamide,Ethambutol)anti-tuberculosis regimen for one year.The observation group was additionally treated with Zhonghe Decoction for 6 months.Abscess size,Traditional Chinese Medicine(TCM)syndrome score,quality of life score,and adverse reactions were evaluated in both groups before treatment,at 6 weeks,and at 24 weeks of treatment.Results:At 6 weeks of treatment,the abscess improvement rate in the observation group was 77.78%(28/36),significantly higher than that in the control group(32.43%,12/37)(x2=15.150,P<0.05);the total effective rate for TCM syndrome efficacy was 88.89%(32/36)in the observation group,also superior to that in the control group(27.03%,10/37)(x2=28.590,P<0.05).At 24 weeks of treatment,the favorable outcome rate in the observation group was 72.22%(26/36),significantly higher than that in the control group(27.03%,10/37)(x2=14.920,P<0.05).Regarding quality of life,,after 6 weeks of treatment,the median(interquartile range)score for physical functioning in the observation group was 3.98(—0.42,8.38),while that in the control group was 0.34(—4.86,5.53),with a statistically significant difference(Z=226.290,P<0.05).The score for role-physical in the observation group was 59.93(20.36,99.50),compared to 33.24(—26.76,93.23)in the control group,showing a statistically significant difference(Z=212.203,P<0.05).The score for bodily pain in the observation group was 24.50(—4.75,53.75),while that in the control group was 12.50(—4.12,24.50),with a statistically significant difference(Z=224.837,P<0.05).No serious adverse events occurred in two groups.Conclusion:Zhonghe Decoction can promote the absorption of abscesses in lymph node tuberculosis,accelerate symptom relief,and improve patients' quality of life,demonstrating definite efficacy and good safety.

关键词

结核,淋巴结/药物,中草药/随机对照试验

Key words

Tuberculosis,lymph node/Drugs,Chinese herbal/Randomized controlled trial

分类

医药卫生

引用本文复制引用

赵丽萍,梁博文,曹艳华,李波,罗敬月,王桂荣,黄麦玲,宗星煜,曹玉清,姜慧,蔡秋杰,马艳,穆婷婷,刘晓明,刘斌..中和汤辅助治疗气血两虚证脓肿型淋巴结结核的随机对照研究短期疗效观察[J].中国防痨杂志,2026,48(7):1044-1050,7.

基金项目

首都卫生发展科研专项(2022-4-2164) (2022-4-2164)

北京研究型病房卓越计划(BRWEP2024W042160104) Capital's Funds for Health Improvement and Research(2022-4-2164) (BRWEP2024W042160104)

Beijing Research Ward Excellence Program(BRWEP2024W042160104) (BRWEP2024W042160104)

中国防痨杂志

1000-6621

访问量0
|
下载量0
段落导航相关论文